Literature DB >> 33457448

Pharmacogenomics based precision medicine in gastroesophageal cancers: way to move forward?

Shrunjal Shah1, Sarbajit Mukherjee1.   

Abstract

Entities:  

Keywords:  esophageal cancer; gastric cancer; oxaliplatin; pralatrexate; single nucleotide polymorphisms (SNPs)

Year:  2020        PMID： 33457448      PMCID： PMC7781489          DOI： 10.18632/oncoscience.520

Source DB:  PubMed          Journal:  Oncoscience        ISSN： 2331-4737


× No keyword cloud information.
  10 in total

1.  Natural variation in human membrane transporter genes reveals evolutionary and functional constraints.

Authors:  Maya K Leabman; Conrad C Huang; Joseph DeYoung; Elaine J Carlson; Travis R Taylor; Melanie de la Cruz; Susan J Johns; Doug Stryke; Michiko Kawamoto; Thomas J Urban; Deanna L Kroetz; Thomas E Ferrin; Andrew G Clark; Neil Risch; Ira Herskowitz; Kathleen M Giacomini
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-28       Impact factor: 11.205

2.  Pralatrexate in Combination with Oxaliplatin in Advanced Esophagogastric Cancer: A Phase II Trial with Predictive Molecular Correlates.

Authors:  Usha Malhotra; Sarbajit Mukherjee; Christos Fountzilas; Patrick Boland; Austin Miller; Santosh Patnaik; Kristopher Attwood; Sai Yendamuri; Araba Adjei; Eric Kannisto; Mateusz Opyrchal; Peter Bushunow; Peter Loud; Renuka Iyer; Nikhil Khushalani
Journal:  Mol Cancer Ther       Date:  2019-10-01       Impact factor: 6.261

3.  Evaluation of the Association of Perioperative UGT1A1 Genotype-Dosed gFOLFIRINOX With Margin-Negative Resection Rates and Pathologic Response Grades Among Patients With Locally Advanced Gastroesophageal Adenocarcinoma: A Phase 2 Clinical Trial.

Authors:  Daniel V T Catenacci; Leah Chase; Samantha Lomnicki; Theodore Karrison; Robert de Wilton Marsh; Murtuza M Rampurwala; Sunil Narula; Lindsay Alpert; Namrata Setia; Shu-Yuan Xiao; John Hart; Uzma D Siddiqui; Bryan Peterson; Kelly Moore; Kristin Kipping-Johnson; Ugne Markevicius; Barbara Gordon; Kenisha Allen; Christine Racette; Steven B Maron; Chih-Yi Liao; Blase N Polite; Hedy L Kindler; Kiran Turaga; Vivek N Prachand; Kevin K Roggin; Mark K Ferguson; Mitchell C Posner
Journal:  JAMA Netw Open       Date:  2020-02-05

Review 4.  Pharmacogenetics/genomics of membrane transporters in cancer chemotherapy.

Authors:  Ying Huang
Journal:  Cancer Metastasis Rev       Date:  2007-03       Impact factor: 9.264

5.  Overexpression of miR-200c induces chemoresistance in esophageal cancers mediated through activation of the Akt signaling pathway.

Authors:  Rie Hamano; Hiroshi Miyata; Makoto Yamasaki; Yukinori Kurokawa; Johji Hara; Jeong Ho Moon; Kiyokazu Nakajima; Shuji Takiguchi; Yoshiyuki Fujiwara; Masaki Mori; Yuichiro Doki
Journal:  Clin Cancer Res       Date:  2011-01-19       Impact factor: 12.531

6.  Global cancer statistics, 2012.

Authors:  Lindsey A Torre; Freddie Bray; Rebecca L Siegel; Jacques Ferlay; Joannie Lortet-Tieulent; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2015-02-04       Impact factor: 508.702

Review 7.  Advanced gastric cancer: Current treatment landscape and future perspectives.

Authors:  Antonia Digklia; Anna Dorothea Wagner
Journal:  World J Gastroenterol       Date:  2016-02-28       Impact factor: 5.742

8.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

9.  Distinct mechanistic activity profile of pralatrexate in comparison to other antifolates in in vitro and in vivo models of human cancers.

Authors:  E Izbicka; A Diaz; R Streeper; M Wick; D Campos; R Steffen; M Saunders
Journal:  Cancer Chemother Pharmacol       Date:  2009-02-17       Impact factor: 3.333

10.  MicroRNA Expression Profiles in Gastric Carcinogenesis.

Authors:  Jinha Hwang; Byung-Hoon Min; Jiryeon Jang; So Young Kang; Hyunsik Bae; Se Song Jang; Jong-Il Kim; Kyoung-Mee Kim
Journal:  Sci Rep       Date:  2018-09-26       Impact factor: 4.379
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.